Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine added to usual GP consultations for mild depression
NL-OMON20223Active, not recruiting
- Sponsor
- Amsterdam UMC
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of paroxetine in major depressive disorder (MDD) (2 arms), sponsored by Amsterdam UMC. Primary endpoints: Depression severity and Remission from depression. Started Jan 2002; status: active, not recruiting.
02
Drugs
paroxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON20223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20223.